Keywords: Uterus, Uterus
Motivation: High-intensity focused ultrasound ablation has been used as a non-invasive method for treating uterine fibroids. However, no reliable method exists to predict the regrowth of residual fibroids.
Goal(s): Aim to provide clues for predicting the efficacy and tumor regrowth of HIFU ablation treatment in patients with uterine fibroids.
Approach: We compared the clinical features and MRI parameters of uterine fibroid before treatment and those of regrowth.
Results: Lower T2 signal intensity of uterine fibroid was associated with better treatment outcomes. The iAUC value might associate with residual fibroid regrowth. MRI can be used to assess the outcome of HIFU treatment for uterine fibroids.
Impact: We found the value of MRI in predicting the efficacy and tumor regrowth of HIFU treatment in patients with uterine fibroids. It is important for targeted disease management and has the potential to extend the duration of uterine fib reduction.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords